News | PET-CT | March 26, 2020

High-resolution PET/CT Assesses Brain Stem Function in Patients with Hearing Impairment

Novel scanners may open door for prognostic assessment in patients receiving cochlear implants

Novel scanners may open door for prognostic assessment in patients receiving cochlear implants

Iva Speck, MD, explains research showing that novel, fully digital, high-resolution positron emission tomography/computed tomography imaging of small brain stem nuclei can provide clinicians with valuable information concerning the auditory pathway in patients with hearing impairment. The research is featured in The Journal of Nuclear Medicine (read more at http://jnm.snmjournals.org/content/current). Video courtesy of Iva Speck, University Hospital Freiburg, Germany.

March 26, 2020 — Novel, fully digital, high-resolution positron emission tomography/computed tomography (PET/CT) imaging of small brain stem nuclei can provide clinicians with valuable information concerning the auditory pathway in patients with hearing impairment, according to a new study published in the March issue of The Journal of Nuclear Medicine. Using 18F-FDG PET/CT imaging, researchers found that patients with asymmetrical hearing loss have reduced glucose metabolism in parts of the brain stem and primary auditory cortex. The latter may be influenced by cortical reorganization and thus, hopefully help to predict the chance that a cochlear implant will improve hearing.

"With the possible exception of few dedicated high-resolution research scanners, earlier PET/CT systems with lower resolution did not permit clear-cut identification and assessment of brain stem nuclei," said Iva Speck, M.D., resident of otorhinolaryngology at the University of Freiburg Medical Center in Freiberg, Germany. "Today, the use of fully digital clinical PET/CT systems permits greatly enhanced imaging and quantitative assessment of small brain stem nuclei, such as the inferior colliculus (IC), the part of the midbrain that acts as a main auditory pathway for the body."

In the study, 13 patients with asymmetric hearing loss underwent 18F-FDG PET/CT imaging. The scans were reviewed by two experienced readers who examined regional glucose metabolism in the IC and the primary auditory cortex (PAC) — a part of the brain known to undergo metabolic changes based on acoustical outside input and transformation to neuronal signals from the cochlea hair cells to the auditory nerve fibers. The readers rated the scans as to whether glucose metabolism showed no asymmetry or mild, moderate or strong asymmetry to the left or to the right for the IC and PAC separately. Statistical analyses were performed to determine the effect of the duration of hearing impairment on glucose metabolism and to compare glucose metabolism between the IC and PAC.

Regional glucose metabolism of both the IC and PAC was significantly reduced on the contralateral (opposite) side of the poorer-hearing ear, as compared to the ipsilateral (same) side. In addition, a longer duration of hearing impairment was associated with a higher metabolism on the contralateral PAC. By contrast, duration of hearing impairment did not predict regional glucose metabolism for the ipsilateral PAC or either side of the IC.

"Previous studies suggest that the association between longer duration of hearing impairment and higher glucose metabolism indicates cortical reorganization. In bilateral deaf patients this has been shown to lessen the benefits of cochlear implants," said Speck. "Prediction of a successful cochlear implant outcome might benefit from improved imaging with fully digital PET/CT systems, as large parts of the auditory system, including small brain nuclei such as the IC, can be assessed for preoperative patient characterization."

She continued, "Beyond this topic, the study's findings are of interest for other neurological research fields, like neurodegenerative diseases, which often affect brain stem nuclei early in disease course," Speck remarked. "Digital PET pushes the limits of what can be imaged and contributed to patient care by molecular imaging."

For more information: www.snmmi.org

View the YouTube video, High-Resolution PET/CT Imaging Assesses Brain Stem Function in Patients with Hearing Impairment.

Related Content

Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.

Getty Images

News | Prostate Cancer | September 24, 2021
September 24, 2021 — Scientists have identified two subtypes of metastatic...
Owkin, a startup that deploys artificial intelligence (AI) and Federated Learning technologies to augment medical research and enable scientific discoveries, presented findings in Hepatocellular Carcinoma (HCC) with Cleveland Clinic at the 2021 European Society of Medical Oncology (ESMO) conference.

Illustration courtesy of Cleveland Clinic

News | Artificial Intelligence | September 24, 2021
September 24, 2021 — Owkin, a startup that deploys...
The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report

Image courtesy of Varian

News | Radiation Therapy | September 24, 2021
September 24, 2021 — The ...
The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.

VCU Massey Cancer Center director and SPORE principal investigator Dr. Robert Winn explains how this grant will help combat racial inequities in lung cancer. Image courtesy of VCU Massey Cancer Center

News | Lung Imaging | September 23, 2021
September 23, 2021 — The National Cancer Institute announced tha
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging.

An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging. Illustration by Arjun Valiya Parambathu

News | Magnetic Resonance Imaging (MRI) | September 20, 2021
September 20, 2021 — ...
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Strategies to help guide nuclear radiology teams at various healthcare systems in 2021 and beyond
Feature | Nuclear Imaging | September 16, 2021 | By Staff of the American Society of Nuclear Cardiology (ASNC)
A year after COVID-19 turned the world upside do